| dc.creator | Soares CRP | |
| dc.creator | Oliveira-Júnior JB | |
| dc.creator | Firmo EF. | |
| dc.date | 2023-03-31T15:28:54Z | |
| dc.date | 2023-03-31T15:28:54Z | |
| dc.date | 2020 | |
| dc.date.accessioned | 2023-09-26T22:27:22Z | |
| dc.date.available | 2023-09-26T22:27:22Z | |
| dc.identifier | Soares CRP, Oliveira-Júnior JB, Firmo EF. First report of a blaNDM-resistant gene in a Klebsiella aerogenes clinical isolate from Brazil. Rev Soc Bras Med Trop. 2020. | |
| dc.identifier | 0037-8682 | |
| dc.identifier | https://www.arca.fiocruz.br/handle/icict/57643 | |
| dc.identifier | 10.1590/0037-8682-0262-2020 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8879452 | |
| dc.description | Carbapenemase-resistant enterobacteria that produce the blaNDM gene are found worldwide. However, this is the first
report of blaNDM in Klebsiella aerogenes in Brazil. Methods: The identification of bacterial species was performed using anautomated
system and confirmed by biochemical tests, 16S rRNA gene sequencing, and detection of resistance genes. Results: The clinical isolate
showed minimum inhibitory concentration resistance to meropenem and polymyxin B at 8mg/L and 4mg/L, respectively. Only the
blaNDM gene was detected. Conclusions: The current report of the bla NDM gene in isolated MDR enterobacteria indicates that this gene
can spread silently in a hospital setting. | |
| dc.format | application/pdf | |
| dc.language | eng | |
| dc.rights | restricted access | |
| dc.subject | Klebsiella aerogenes | |
| dc.subject | blaNDM gene | |
| dc.subject | metallo-betalactamase | |
| dc.subject | Carbapenemase | |
| dc.subject | Multidrug-resistant | |
| dc.title | First report of a blaNDM-resistant gene in a Klebsiella aerogenes clinical isolate from Brazil | |
| dc.type | Article | |